000 | 01990 a2200601 4500 | ||
---|---|---|---|
005 | 20250514222558.0 | ||
264 | 0 | _c20050801 | |
008 | 200508s 0 0 eng d | ||
022 | _a0006-4971 | ||
024 | 7 |
_a10.1182/blood-2005-01-0341 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBodin, Laurent | |
245 | 0 | 0 |
_aCytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity. _h[electronic resource] |
260 |
_bBlood _cJul 2005 |
||
300 |
_a135-40 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcenocoumarol _xadministration & dosage |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xgenetics |
650 | 0 | 4 | _aCarcinoma, Hepatocellular |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCytochrome P-450 CYP2C9 |
650 | 0 | 4 |
_aDrug Resistance _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Frequency |
650 | 0 | 4 | _aGenes, Reporter |
650 | 0 | 4 | _aHaplotypes |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLinear Models |
650 | 0 | 4 | _aLiver Neoplasms |
650 | 0 | 4 |
_aLuciferases _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMixed Function Oxygenases _xgenetics |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aVitamin K Epoxide Reductases |
700 | 1 | _aVerstuyft, Céline | |
700 | 1 | _aTregouet, David-Alexandre | |
700 | 1 | _aRobert, Annie | |
700 | 1 | _aDubert, Liliane | |
700 | 1 | _aFunck-Brentano, Christian | |
700 | 1 | _aJaillon, Patrice | |
700 | 1 | _aBeaune, Philippe | |
700 | 1 | _aLaurent-Puig, Pierre | |
700 | 1 | _aBecquemont, Laurent | |
700 | 1 | _aLoriot, Marie-Anne | |
773 | 0 |
_tBlood _gvol. 106 _gno. 1 _gp. 135-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2005-01-0341 _zAvailable from publisher's website |
999 |
_c15461683 _d15461683 |